Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens

被引:33
作者
Chopra, Teena [1 ,2 ]
Zhao, Jing J. [3 ]
Alangaden, George [1 ,2 ]
Wood, Michael H. [2 ,4 ]
Kaye, Keith S. [1 ,2 ]
机构
[1] Wayne State Univ, Dept Med, Div Infect Dis, Detroit, MI 48201 USA
[2] Detroit Med Ctr, Detroit, MI 48201 USA
[3] Harper Univ Hosp, Dept Pharm, Detroit Med Ctr, Detroit, MI USA
[4] Wayne State Univ, Bariatr Surg, Detroit, MI 48201 USA
关键词
anastomotic leak; antibiotic prophylaxis; bariatric surgery; port infection; surgical site infection; wound infection; ANTIMICROBIAL RESISTANCE TRENDS; MORBIDLY OBESE-PATIENTS; Y GASTRIC BYPASS; WOUND-INFECTION; VANCOMYCIN PHARMACOKINETICS; ADVISORY STATEMENT; ANASTOMOTIC LEAKS; CLINICAL-TRIALS; NORMAL-WEIGHT; RISK-FACTORS;
D O I
10.1586/ERP.10.26
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Bariatric surgery for obesity has emerged as an effective and commonly used treatment modality. This paper reviews the surgical site infections (SSIs) that occur post bariatric surgery and SSI prevention. The benefit of bariatric surgery resulting in profound weight loss brings with it consequences in the form of postoperative complications that can have profound effects on morbidity and mortality in these patients. This paper sets out to define different types of SSIs that occur following bariatric surgery and to discuss existing literature on the critical aspects of SSI prevention and the appropriate use of surgical antimicrobial prophylaxis for bariatric surgery.
引用
收藏
页码:317 / 328
页数:12
相关论文
共 92 条
[21]   Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project [J].
Bratzler, DW ;
Houck, PM .
AMERICAN JOURNAL OF SURGERY, 2005, 189 (04) :395-404
[22]   DEFINITION OF THE ROLE OF ENTEROCOCCUS IN INTRAABDOMINAL INFECTION - ANALYSIS OF A PROSPECTIVE RANDOMIZED TRIAL [J].
BURNETT, RJ ;
HAVERSTOCK, DC ;
DELLINGER, EP ;
REINHART, HH ;
BOHNEN, JM ;
ROTSTEIN, OD ;
VOGEL, SB ;
SOLOMKIN, JS .
SURGERY, 1995, 118 (04) :716-723
[23]  
Cadiere G B, 2002, Semin Laparosc Surg, V9, P105, DOI 10.1053/slas.2002.126331
[24]   INTRAVENOUS CIPROFLOXACIN DOSING IN A MORBIDLY OBESE PATIENT [J].
CALDWELL, JB .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (06) :806-806
[25]   Obesity and mortality [J].
Calle, EE ;
Teras, LR ;
Thun, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2197-2199
[26]   Comparative pharmacokinetics and pharmacodynamic target attainment of ertapenem in normal-weight, obese, and extremely obese adults [J].
Chen, M ;
Nafziger, AN ;
Drusano, GL ;
Ma, L ;
Bertino, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1222-1227
[27]   CEFOTIAM DISPOSITION IN MARKEDLY OBESE ATHLETE PATIENTS, JAPANESE SUMO WRESTLERS [J].
CHIBA, K ;
TSUCHIYA, M ;
KATO, J ;
OCHI, K ;
KAWA, Z ;
ISHIZAKI, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1188-1192
[28]  
Chopra TCK, 2009, INT C ANT AG CHEM SA
[29]   Analysis of the incidence and risk factors for wound infections in open bariatric surgery [J].
Christou, NV ;
Jarand, J ;
Sylvestre, JL ;
McLean, APH .
OBESITY SURGERY, 2004, 14 (01) :16-22
[30]   Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections [J].
Cohn, SM ;
Lipsett, PA ;
Buchman, TG ;
Cheadle, WG ;
Milsom, JW ;
O'Marro, S ;
Yellin, AE ;
Jungerwirth, S ;
Rochefort, EV ;
Haverstock, DC ;
Kowalsky, SF .
ANNALS OF SURGERY, 2000, 232 (02) :254-262